In 2008, the Federal Court for Tax and Administrative Affairs
(FCTAA) created a Specialized IP Court to decide all the cases
related to IP rights, which started work in January 2009.
But whenever cases referred to arguments based on International
IP Treaties, such as the Paris Convention or TRIPS, the files were
sent to the High Bench of the FCTAA, as this Bench had exclusive
jurisdiction in this regard.
This generated two separate problems: the magistrates of the
High Bench mostly specialized in tax issues and decisions were
delayed for months, due to the Bench's backlog.
As a result the internal law of the FCTAA was amended last
month, empowering Specialized Courts to decide cases based on
At this point the only Specialized Court at the FCTAA is the IP
Court, but there are plans to open additional Specialized Courts,
starting with one on antitrust issues.
Additionally, the Federal Contentious Administrative Proceedings
Law (FCAPL) was amended to establish the "via sumaria"
(summary venue). This reform should reduce the periods provided to
parties, authorities, and the FCTAA to prosecute the nullity trial,
by establishing shorter deadlines.
At this venue, once the Court admits the trial, it has to
indicate the date to review and determine if the trial is ready for
the issuance of the decision on the merits, which cannot exceed 60
Lawsuits challenging administrative decisions going against
precedents set forth by the Mexican Supreme Court concerning
unconstitutional laws, or precedents from the High Bench of the
FCTAA, can be studied under this new venue.
The summary venue cannot be used for fines imposed for
infringement of IP rights, and therefore it will not be used in
patent or trademark infringement cases, but cancellation cases and
other decisions by the Mexican authorities with jurisdiction on IP
matters could be challenged through it.
The content of this article is intended to provide a general
guide to the subject matter. Specialist advice should be sought
about your specific circumstances.
To print this article, all you need is to be registered on Mondaq.com.
Click to Login as an existing user or Register so you can print this article.
As you already know, for the allowance of pharmaceutical
patents, the Brazilian IP Law currently requires the prior consent
from ANVISA (Brazilian Health Surveillance Agency –
equivalent to American FDA) along with the usual examination from
Please be informed that the devaluation of 59% on the exchange rate used to calculate the official fees for foreign IP owners announced by the Government on February 18 has been finally published in the Official Gazette No. 40.865.
Peru has been recognized as one of the seventeen megadiverse countries in the planet for being holder of more than 70% of the planet's biodiversity.
Some comments from our readers… “The articles are extremely timely and highly applicable” “I often find critical information not available elsewhere” “As in-house counsel, Mondaq’s service is of great value”
This service is completely free. Access 250,000 archived articles from 100+ countries and get a personalised email twice a week covering developments (and yes, our lawyers like to think you’ve read our Disclaimer).